BEAM
Price
$23.84
Change
-$0.42 (-1.73%)
Updated
Sep 28, 9:57 AM EST
39 days until earnings call
NTLA
Price
$31.39
Change
-$0.70 (-2.18%)
Updated
Sep 28, 9:45 AM EST
35 days until earnings call

Compare trend and price BEAM vs NTLA

Header iconBEAM vs NTLA Comparison
Open Charts BEAM vs NTLABanner chart's image
Beam Therapeutics
Price$23.84
Change-$0.42 (-1.73%)
Volume$500
CapitalizationN/A
Intellia Therapeutics
Price$31.39
Change-$0.70 (-2.18%)
Volume$100
CapitalizationN/A
View a ticker or compare two or three
BEAM vs NTLA Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
BEAM vs. NTLA commentary
Sep 28, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and NTLA is a Hold.

COMPARISON
Comparison
Sep 28, 2023
Stock price -- (BEAM: $24.26 vs. NTLA: $32.09)
Brand notoriety: BEAM and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 89% vs. NTLA: 122%
Market capitalization -- BEAM: $1.82B vs. NTLA: $2.85B
BEAM [@Biotechnology] is valued at $1.82B. NTLA’s [@Biotechnology] market capitalization is $2.85B. The market cap for tickers in the [@Biotechnology] industry ranges from $407B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileNTLA’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than NTLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while NTLA’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 3 bearish.
  • NTLA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than NTLA.

Price Growth

BEAM (@Biotechnology) experienced а -3.84% price change this week, while NTLA (@Biotechnology) price change was -5.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.49%. For the same industry, the average monthly price growth was +17.74%, and the average quarterly price growth was +35.12%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 06, 2023.

NTLA is expected to report earnings on Nov 02, 2023.

Industries' Descriptions

@Biotechnology (+2.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BEAM with price predictions.
OPEN
A.I.dvisor published
a Summary for NTLA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
NTLA($2.85B) has a higher market cap than BEAM($1.82B). NTLA YTD gains are higher at: -8.025 vs. BEAM (-37.970). BEAM has higher annual earnings (EBITDA): -364.48M vs. NTLA (-451.71M). BEAM has more cash in the bank: 1.07B vs. NTLA (908M). NTLA has less debt than BEAM: NTLA (122M) vs BEAM (175M). BEAM has higher revenues than NTLA: BEAM (80.2M) vs NTLA (53M).
BEAMNTLABEAM / NTLA
Capitalization1.82B2.85B64%
EBITDA-364.48M-451.71M81%
Gain YTD-37.970-8.025473%
P/E RatioN/AN/A-
Revenue80.2M53M151%
Total Cash1.07B908M118%
Total Debt175M122M143%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
97
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMNTLA
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 18 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BRUSX24.890.17
+0.69%
Bridgeway Ultra-Small Company
EQIRX9.950.02
+0.20%
Allspring Emerging Markets Eq Inc R6
DQIYX24.380.03
+0.12%
BNY Mellon Equity Income Fund Y
FVDFX33.620.03
+0.09%
Fidelity® Value Discovery
AMFCX47.09N/A
N/A
American Funds American Mutual C